P A Brady, J Al-Suwaidi, S L Kopecky, A Terzic. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AgedAged, 80 and overComorbidityDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyFollow-Up StudiesHeart/drug effectsHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/pharmacologyHypoglycemic Agents/therapeutic useInsulin/therapeutic useIon Channel Gating/drug effectsLife TablesMyocardial Infarction/complicationsMyocardial Infarction/mortalityPotassium Channels/drug effectsSulfonylurea Compounds/adverse effectsSulfonylurea Compounds/pharmacologySulfonylurea Compounds/therapeutic useSurvival AnalysisTreatment Outcome
Substances: See more » Hypoglycemic AgentsInsulinPotassium ChannelsSulfonylurea Compounds
Year: 1998 PMID: 9495313
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690